Viewing Study NCT07049692


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-01-02 @ 11:46 AM
Study NCT ID: NCT07049692
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-27
First Post: 2025-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Efficacy and Safety of Hyperbaric Oxygen Combined With Endovascular Treatment in Patients With Acute Ischemic Stroke
Sponsor: Beijing Chao Yang Hospital
Organization:

Study Overview

Official Title: Evaluation of the Efficacy and Safety of Hyperbaric Oxygen Combined With Endovascular Treatment in Patients With Acute Ischemic Stroke: A Multicenter, Open-label, Randomized Controlled Clinical Trial
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NOTICE-1
Brief Summary: 1. The goal of this clinical trial is to evaluate the efficacy and safety of hyperbaric oxygen (HBO) combined with endovascular treatment in patients with acute ischemic stroke.
2. The main questions it aims to answer is:

Whether HBO combined with endovascular treatment can improve the prognosis of ischemic stroke?
3. Participants will :

receive HBO or high-flow oxygen treatment, administered once daily for 10 consecutive sessions.

undergo three scheduled telephone follow-up assessments during the 12-month period following HBO.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2025-3-4-2 REGISTRY NOTICE-1 View